carbostyril has been researched along with Dyspnea in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 27 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, A; Dezube, R; Grant, J; Hong, G; Jennings, MT; Lechtzin, N; Merlo, CA; Paranjape, S; West, NE | 1 |
| Cao, W; Decuypère, L; Devouassoux, G; Girodet, PO; Jasnot, JY; Le Gros, V | 1 |
| Banerji, D; Fogel, R; Fucile, S; Kostikas, K; Mezzi, K; Shen, S; Tsiligianni, I | 1 |
| Aalamian-Mattheis, M; Castellani, W; Clemens, A; Gaga, M; Greulich, T; Kostikas, K; Lane, S; Marin, JM; Ninane, V; Nunez, X; Patalano, F; Vogelmeier, CF | 1 |
| Aalamian-Mattheis, M; Clemens, A; Fogel, R; Kostikas, K; Nunez, X; Pagano, VA; Patalano, F | 1 |
| Feldman, GJ | 1 |
| Buhl, R; Lawrence, D; Mahler, DA; McBryan, D | 1 |
| Connolly, MJ; Hanania, NA; Yohannes, AM | 1 |
| Dai, L; Han, J; Zhong, N | 1 |
| Alagappan, VK; Banerji, D; Chen, H; D'Urzo, A; Decramer, M; Gallagher, N; Kulich, K; Mahler, DA; White, T; Worth, H | 1 |
| Singh, MP | 1 |
| Centanni, S; D'Angelo, E; Di Marco, F; Henchi, S; Pecchiari, M; Radovanovic, D; Santus, P | 1 |
| Guenette, JA; Molgat-Seon, Y; Quon, BS; Schaeffer, MR; Wilcox, PG; Wilkie, SS | 1 |
| Cazzola, M; Matera, MG; Rogliani, P | 1 |
| Cockle, SM; Huisman, EL; Ismaila, AS; Karabis, A; Punekar, YS | 1 |
| Blasi, F; Bussotti, M; Centanni, S; Di Marco, S; Raccanelli, R; Radovanovic, D; Santus, P; Valenti, V | 1 |
| Lee, JS; Oh, YM; Park, J; Rhee, C | 1 |
| Bourdeix, I; Burgel, PR; Decuypère, L; Deslée, G; Le Gros, V; Perez, T | 1 |
| Donohue, JF; Fogarty, C; Higgins, M; Iqbal, A; Kramer, B; Lötvall, J; Mahler, DA; Owen, R; Swales, J; Worth, H; Yorgancioglu, A | 1 |
| Centanni, S; Dahl, R; Dogra, A; Kornmann, O; Kramer, B; Lassen, C; Owen, R | 1 |
| Gale, R; Jones, PW; Kramer, B; Mahler, DA; Owen, R | 1 |
| Beeh, KM; Drollmann, AF; Khindri, S; Wagner, F | 1 |
| Chyczewska, E; Minarowski, L; Mroz, RM | 1 |
| Capkun-Niggli, G; Cope, S; Jansen, JP; Kraemer, M; Zhang, J | 1 |
| Gotfried, MH; Kerwin, EM; Kramer, B; Lassen, C; Lawrence, D | 1 |
| Fukuchi, Y; Hang, LW; Ichinose, M; Kinoshita, M; Kitawaki, T; Kramer, B; Lawrence, D; Lee, SH; Okino, N; Prasad, N; To, Y | 1 |
| Dahl, R; Decramer, M; Korn, S; Kornmann, O; Lawrence, D; McBryan, D | 1 |
8 review(s) available for carbostyril and Dyspnea
| Article | Year |
|---|---|
Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Dyspnea; Exercise Tolerance; Humans; Indans; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Severity of Illness Index | 2013 |
Ten years of tiotropium: clinical impact and patient perspectives.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Bronchodilator Agents; Dyspnea; Ethanolamines; Formoterol Fumarate; Humans; Indans; Medication Adherence; Mucociliary Clearance; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide | 2013 |
Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials.
Topics: Adrenergic beta-2 Receptor Agonists; Dyspnea; Humans; Indans; Placebos; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic | 2013 |
QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Bronchodilator Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Dyspnea; Glycopyrrolate; Humans; Indans; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones | 2015 |
Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis.
Topics: Bronchodilator Agents; Drug Combinations; Drug Therapy, Combination; Dyspnea; Forced Expiratory Volume; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Tiotropium Bromide; Treatment Outcome | 2015 |
Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchodilator Agents; Cough; Dyspnea; Forced Expiratory Volume; Humans; Indans; Placebos; Pulmonary Disease, Chronic Obstructive; Quinolones; Sputum; Surveys and Questionnaires; Treatment Outcome | 2015 |
Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.
Topics: Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Therapy, Combination; Dyspnea; Ethanolamines; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic | 2012 |
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide; Treatment Outcome; Vital Capacity | 2013 |
14 trial(s) available for carbostyril and Dyspnea
| Article | Year |
|---|---|
Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.
Topics: Aged; Bronchodilator Agents; Drug Combinations; Dyspnea; Female; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Glucocorticoids; Glycopyrrolate; Health Status; Humans; Indans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Severity of Illness Index; Sex Factors; Tiotropium Bromide; Vital Capacity | 2017 |
Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Bronchodilator Agents; Disease Progression; Drug Combinations; Drug Substitution; Dyspnea; Europe; Female; Forced Expiratory Volume; Glycopyrrolate; Health Status; Humans; Indans; Lung; Male; Middle Aged; Muscarinic Antagonists; Patient Safety; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Recovery of Function; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2017 |
Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study.
Topics: Aged; Bronchodilator Agents; Drug Combinations; Dyspnea; Female; Forced Expiratory Volume; Glycopyrrolate; Humans; Indans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Reported Outcome Measures; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolones; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2018 |
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study.
Topics: Adult; Aged; Area Under Curve; Bronchodilator Agents; Cross-Over Studies; Drug Combinations; Dyspnea; Female; Forced Expiratory Volume; Glycopyrrolate; Humans; Indans; Male; Middle Aged; Powders; Pulmonary Disease, Chronic Obstructive; Quinolones; Scopolamine Derivatives; Spirometry; Tiotropium Bromide; Treatment Outcome | 2014 |
Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients.
Topics: Adrenergic beta-Agonists; Aged; Airway Resistance; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dyspnea; Female; Humans; Indans; Lung Volume Measurements; Male; Plethysmography; Pulmonary Disease, Chronic Obstructive; Quinolones; Respiratory Function Tests; Time Factors; Treatment Outcome | 2014 |
Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Airway Resistance; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dyspnea; Echocardiography; Female; Forced Expiratory Volume; Humans; Indans; Inspiratory Capacity; Lung Volume Measurements; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolones; Treatment Outcome | 2015 |
Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Dose-Response Relationship, Drug; Dyspnea; Female; Forced Expiratory Volume; France; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Vital Capacity | 2017 |
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
Topics: Administration, Inhalation; Blood Glucose; Bronchodilator Agents; Double-Blind Method; Drug Administration Schedule; Dyspnea; Electrocardiography; Female; Forced Expiratory Volume; Health Status; Humans; Indans; Male; Middle Aged; Potassium; Pulmonary Disease, Chronic Obstructive; Quinolones; Scopolamine Derivatives; Spirometry; Tiotropium Bromide | 2010 |
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison.
Topics: Adrenal Cortex Hormones; Aged; Albuterol; Bronchodilator Agents; Drug Administration Schedule; Dyspnea; Female; Health Status; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Respiratory Function Tests; Salmeterol Xinafoate; Smoking; Surveys and Questionnaires | 2011 |
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Double-Blind Method; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Health Status; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate | 2011 |
Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Cross-Over Studies; Double-Blind Method; Dyspnea; Exercise Tolerance; Female; Forced Expiratory Volume; Humans; Indans; Inspiratory Capacity; Linear Models; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Treatment Outcome | 2011 |
Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Bronchodilator Agents; Dyspnea; Exercise; Exercise Tolerance; Female; Forced Expiratory Volume; Humans; Indans; Lung; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Pulmonary Ventilation; Quality of Life; Quinolones; Receptors, Adrenergic, beta-2; Respiratory Function Tests; Surveys and Questionnaires | 2013 |
Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Analysis of Variance; Double-Blind Method; Drug Administration Schedule; Dyspnea; Female; Forced Expiratory Volume; Health Status Indicators; Humans; Indans; Logistic Models; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Surveys and Questionnaires; Treatment Outcome | 2012 |
Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.
Topics: Adult; Aged; Asia; Bronchodilator Agents; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Health Status; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Sleep Wake Disorders; Treatment Outcome; Vital Capacity | 2012 |
5 other study(ies) available for carbostyril and Dyspnea
| Article | Year |
|---|---|
An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Dyspnea; Female; Forced Expiratory Volume; Humans; Logistic Models; Lung; Male; Middle Aged; Mutation; Quinolones; Retrospective Studies; Young Adult | 2017 |
Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Bronchodilator Agents; Clinical Trials, Phase III as Topic; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Formoterol Fumarate; Health Status; Humans; Indans; Male; Middle Aged; Netherlands; Prevalence; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Severity of Illness Index; Smoking; Tiotropium Bromide; Treatment Outcome; Vital Capacity | 2017 |
Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.
Topics: Bronchodilator Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyspnea; Forced Expiratory Volume; Humans; Indans; Patient Acuity; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Scopolamine Derivatives; Tiotropium Bromide | 2013 |
Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Bronchodilator Agents; Drug Substitution; Drug Therapy, Combination; Drug Utilization Review; Dyspnea; England; Exercise Tolerance; Female; Forced Expiratory Volume; Humans; Indans; Lung; Male; Medical Audit; Middle Aged; Muscarinic Antagonists; Primary Health Care; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Retrospective Studies; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2013 |
Physiological mechanisms of dyspnea relief following ivacaftor in cystic fibrosis: a case report.
Topics: Adult; Aminophenols; Cystic Fibrosis; Dyspnea; Exercise Tolerance; Humans; Male; Quinolones; Respiratory Function Tests; Respiratory Physiological Phenomena | 2015 |